Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study
2003 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Tumor-Derived Tissue FactorBearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy
2009
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
2000 Standout
Endoscopic mucosal resection for treatment of early gastric cancer
2001 Standout
Early gastric cancer in Europe
1997
Primary thromboprophylaxis for cancer patients with central venous catheters – a reappraisal of the evidence
2006
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Anticoagulation for patients with cancer and central venous catheters
2011
Venous thromboembolic disease and cancer
2006
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
A pilot study of central venous catheter survival in cancer patients using low‐molecular‐weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study)
2007
GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
2011 Standout
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
Contribution of platelets to tumour metastasis
2011 Standout
ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer
2010
Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer
1997
Prevention of VTE in Orthopedic Surgery Patients
2012 Standout
Management of occlusion and thrombosis associated with long-term indwelling central venous catheters
2009
Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation.
1997
The hidden sentinel node in breast cancer
2002
Antithrombotic Therapy for VTE Disease
2016 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation
2001 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Vascular disorders of the liver # †
2008 Standout
Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)
1999
Molecular mechanisms of cisplatin resistance
2011 Standout
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Current perspective of venous thrombosis in the upper extremity
2008
Antithrombotic Therapy for VTE Disease
2012 Standout
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
2004 Standout
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial
2005
The golden age: gold nanoparticles for biomedicine
2011 Standout
Executive Summary
2012 Standout
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.
1997
Anticoagulation for patients with cancer and central venous catheters
2011
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy
1998
Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients
1998
Breast cancer sentinel lymph node mapping using near-infrared guided indocyanine green in comparison with blue dye
2013
Prevention of Venous Thromboembolism
2004 Standout
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation
2011
Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma
2001
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Thrombosis and cancer
2012
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
2001 Standout
In vivo photoacoustic mapping of lymphatic systems with plasmon-resonant nanostars
2011
Venous Thromboembolism in the Outpatient Setting
2007
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Tumor-associated lympho-monocytes from neoplastic effusions are immunologically defective in comparison with patient autologous PBMCs but are capable of releasing high amounts of various cytokines
1997
Prevention of Venous Thromboembolism
2008 Standout
Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial
2002 Standout
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
Risk factors for catheter‐related thrombosis (CRT) in cancer patients: a patient‐level data (IPD) meta‐analysis of clinical trials and prospective studies
2010
Deep-Vein Thrombosis of the Upper Extremities
2011
Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters
2007
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
2009
The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy
2002
A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer
2003 Standout
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Cancer of the Ovary
2004 Standout
Preoperative Lymphoscintigraphy During Lymphatic Mapping for Breast Cancer: Improved Sentinel Node Imaging Using Subareolar Injection of Technetium 99M Sulfur Colloid
2000
Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidence
2003 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Assessing Risk of Venous Thromboembolism in the Patient With Cancer
2009
The increase in immunosuppression and its role in the development of malignant lesions
1985
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
2009 Standout
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
2014
Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With Cancer
2006
Phase I trial of intraperitoneal recombinant interleukin-2/lymphokine-activated killer cells in patients with ovarian cancer.
1990
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
2007 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)
2001
Anticoagulation for people with cancer and central venous catheters
2014
Local recurrence of rectal adenocarcinoma after ‘curative’ surgery with and without preoperative radiotherapy
1994
Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial
2003
Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.
2003
Laparotomy and laparoscopy differentially accelerate experimental flank tumour growth
1998
Evidence-Based Surgical Care and the Evolution of Fast-Track Surgery
2008 Standout
Works of Sergio Bertoglio being referenced
Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracil
1993
New fields of application of the sentinel lymph node biopsy in the pathologic staging of solid neoplasms: Review of literature and surgical perspectives
2004
Factors Influencing Local Recurrence after Curative Surgery for Rectal Cancer
1989
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients
2008
Perilymphatic injections of recombinant interleukin‐2 (rIL‐2) partially correct the immunologic defects in patients with advanced head and neck squamous cell carcinoma
1992
Phenotypic and functional characteristics of tumor‐associated lymphocytes in patients with malignant ascites receiving intraperitoneal infusions of recombinant interleukin‐2 (ril‐2)
1989
Radiation-associated angiosarcoma: Diagnostic and therapeutic implications—Two case reports and a review of the literature
1996
A double-blind placebo-controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter
2004
Long-term postoperative results in 54 cases of early gastric cancer: the choice of surgical procedure.
1989
Immunosuppressive effect of surgery evaluated by the multitest cell-mediated immunity system.
1984
Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study in Cancer Patients
2005
Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
1995
Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer.
1998
Sentinel Lymph Node Mapping and Biopsy for Breast Cancer: A Review of the Literature Relative to 4791 Procedures
1999